69 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33429006 | COX-2 promotes mammary adipose tissue inflammation, local estrogen biosynthesis, and carcinogenesis in high-sugar/fat diet treated mice. | 2021 Apr 1 | 1 |
2 | 33468439 | Probable etoricoxib-induced fixed drug eruption involving the oral mucosa: A case report. | 2021 Apr | 1 |
3 | 33730601 | Etoricoxib may inhibit cytokine storm to treat COVID-19. | 2021 May | 1 |
4 | 34811370 | A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients. | 2021 Nov 22 | 1 |
5 | 32303303 | Detection and Pharmacokinetics of Etoricoxib in Thoroughbred Horses. | 2020 May | 1 |
6 | 32912981 | Comparative efficacy of traditional non-selective NSAIDs and selective cyclo-oxygenase-2 inhibitors in patients with acute gout: a systematic review and meta-analysis. | 2020 Sep 10 | 1 |
7 | 30080442 | Exploring the binding dynamics of etoricoxib with human hemoglobin: A spectroscopic, calorimetric, and molecular modeling approach. | 2019 Jul | 1 |
8 | 31190596 | Utilization of etoricoxib in dental patients in the Nordic countries: a population-based register study. | 2019 Nov | 1 |
9 | 31360199 | Expression of microRNAs in the plasma of patients with acute gouty arthritis and the effects of colchicine and etoricoxib on the differential expression of microRNAs. | 2019 Jul | 1 |
10 | 28954205 | Etoricoxib improves osteoarthritis pain relief, joint function, and quality of life in the extreme elderly. | 2018 Feb 20 | 1 |
11 | 28425581 | Clinical, Biochemical, and Genetic Features of 41 Han Chinese Families With Primary Hypertrophic Osteoarthropathy, and Their Therapeutic Response to Etoricoxib: Results From a Six-Month Prospective Clinical Intervention. | 2017 Aug | 1 |
12 | 28464042 | Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial. | 2017 | 1 |
13 | 25828692 | No effect of the cyclooxygenase-2 inhibitor etoricoxib on pre-emptive and post-operative analgesia in visceral surgery: results of a randomized controlled trial. | 2016 Feb | 1 |
14 | 27372432 | Selective COX-2 Inhibition Exerts No Negative Effects on Peripheral Blood Lymphocytes in Allergic Asthmatics. | 2016 | 2 |
15 | 26548623 | Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed. | 2015 Dec 15 | 1 |
16 | 25340915 | Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease. | 2014 Oct 23 | 1 |
17 | 22882551 | The first example of a patient with etoricoxib-induced immune hemolytic anemia. | 2013 May | 1 |
18 | 23652751 | Increased risk for complications after colorectal surgery with selective cyclo-oxygenase 2 inhibitor etoricoxib. | 2013 Jun | 1 |
19 | 23126318 | Etoricoxib and the treatment of ankylosing spondylitis. | 2012 Dec | 1 |
20 | 21235334 | The use of etoricoxib and celecoxib for pain prevention after periodontal surgery: a double-masked, parallel-group, placebo-controlled, randomized clinical trial. | 2011 Sep | 1 |
21 | 21332932 | Predictors of response to cyclo-oxygenase-2 inhibitors in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib, and placebo. | 2011 Mar | 1 |
22 | 21457143 | Inhibitory effect of selective cyclooxygenase-2 inhibitor etoricoxib on human organic anion transporter 3 (hOAT3). | 2011 Apr | 2 |
23 | 21618455 | Luteinized unruptured follicle syndrome increased by inactive disease and selective cyclooxygenase 2 inhibitors in women with inflammatory arthropathies. | 2011 Sep | 2 |
24 | 20039959 | Prophylactic etoricoxib is effective in preventing Yom Kippur headache: a placebo-controlled double-blind and randomized trial of prophylaxis for ritual fasting headache. | 2010 Sep | 1 |
25 | 20052461 | Absorption and distribution of etoricoxib in plasma, CSF, and wound tissue in patients following hip surgery--a pilot study. | 2010 Feb | 1 |
26 | 20584877 | Pain management after elective hallux valgus surgery: a prospective randomized double-blind study comparing etoricoxib and tramadol. | 2010 Aug | 1 |
27 | 20877132 | Inhibitory effect of selective cyclooxygenase-2 inhibitor lumiracoxib on human organic anion transporters hOAT1 and hOAT3. | 2010 | 1 |
28 | 18952694 | Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation. | 2009 Feb 1 | 1 |
29 | 19338584 | Synthesis of hyaluronan in oesophageal cancer cells is uncoupled from the prostaglandin-cAMP pathway. | 2009 May | 1 |
30 | 19392653 | The cyclooxygenase-2 inhibitor etoricoxib is a potent chemopreventive agent of colon carcinogenesis in the rat model. | 2009 | 2 |
31 | 18405470 | Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. | 2008 Apr | 3 |
32 | 18443385 | Effects of etoricoxib on the pharmacokinetics of phenytoin. | 2008 Mar-Apr | 2 |
33 | 18661871 | Design, development, and optimization of orally disintegrating tablets of etoricoxib using vacuum-drying approach. | 2008 May-Jun | 3 |
34 | 18823299 | Evaluation of the pharmacokinetics of digoxin in healthy subjects receiving etoricoxib. | 2008 Dec | 1 |
35 | 18823986 | Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac. | 2008 Nov | 1 |
36 | 17155937 | Etoricoxib pre-medication combined with intra-operative subacromial block for pain after arthroscopic acromioplasty. | 2007 Mar | 1 |
37 | 17228166 | Etoricoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inflammatory drugs. | 2007 | 1 |
38 | 17278926 | Therapeutic advances in gout. | 2007 Mar | 1 |
39 | 17304885 | Tolerance to etoricoxib in 37 patients with urticaria and angioedema induced by nonsteroidal anti-inflammatory drugs. | 2007 Feb | 2 |
40 | 17691996 | Efficacy of the newest COX-2 selective inhibitors in rheumatic disease. | 2007 | 1 |
41 | 17697449 | Etoricoxib versus naproxen in patients with rheumatoid arthritis: a prospective, randomized, comparator-controlled 121-week trial. | 2007 Sep | 2 |
42 | 17915794 | A study on the effects of diclofenac sodium and etoricoxib in the treatment of osteoarthritis. | 2007 May | 3 |
43 | 18516314 | Update on the treatment of ankylosing spondylitis. | 2007 Dec | 1 |
44 | 16397127 | Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo. | 2006 May 1 | 1 |
45 | 16875903 | Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis. | 2006 Aug | 1 |
46 | 16892790 | Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease. | 2006 Jul | 2 |
47 | 15473012 | A liquid chromatography-mass spectrometry method for the quantification of both etoricoxib and valdecoxib in human plasma. | 2005 Mar | 1 |
48 | 15664353 | Validated liquid chromatographic ultraviolet method for the quantitation of Etoricoxib in human plasma using liquid-liquid extraction. | 2005 Feb 25 | 1 |
49 | 15815733 | [COX-2 inhibitors--one step forward and two steps back]. | 2005 Apr 7 | 2 |
50 | 15818702 | Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study. | 2005 Apr | 2 |